Attached files
| file | filename |
|---|---|
| EX-32 - EX-32 - Recro Pharma, Inc. | d863027dex32.htm |
| EX-31.3 - EX-31.3 - Recro Pharma, Inc. | d863027dex313.htm |
| EX-31.1 - EX-31.1 - Recro Pharma, Inc. | d863027dex311.htm |
| EX-31.2 - EX-31.2 - Recro Pharma, Inc. | d863027dex312.htm |
| EX-10.14 - EX-10.14 - Recro Pharma, Inc. | d863027dex1014.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Recro Pharma, Inc. | Financial_Report.xls |
| 10-K - FORM 10-K - Recro Pharma, Inc. | d863027d10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Recro Pharma Inc.
We consent to the incorporation by reference in the Registration Statements (No. 333-194730) on Form S-8 and (No. 333-201841) on Form S-1 of Recro Pharma, Inc. of our report dated March 25, 2015, with respect to the balance sheets of Recro Pharma, Inc. as of December 31, 2013 and 2014, and the related statements of operations, redeemable convertible preferred stock and shareholders’ equity (deficit), and cash flows for the years then ended, which report appears in the December 31, 2014 annual report on Form 10-K of Recro Pharma, Inc.
| /s/ KPMG LLP |
| Philadelphia, Pennsylvania |
| March 25, 2015 |